| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer
1 company
Barone Francesca is a Chief Scientific Officer at Candel Therapeutics, Inc.. Recent SEC Form 4 filings include 1 buy and 6 sells.
Estimated insider holdings value: $1.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 18, 2025 | CADL Candel Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 32,146 | $8.76 | $281,672.90 | -25.0% | -41.5% | -42.9% | |
| Jan 15, 2025 | CADL Candel Therapeutics, Inc. | Chief Scientific Officer | Sell | 13,534 | $7.23 | $97,783.15 | -10.9% | -38.1% | -25.7% | |
| Jan 8, 2025 | CADL Candel Therapeutics, Inc. | Chief Scientific Officer | Sell | 13,673 | $8.22 | $112,367.45 | -9.9% | -49.7% | -36.4% | |
| Nov 29, 2024 | CADL Candel Therapeutics, Inc. | Chief Scientific Officer | Sell | 22,081 | $4.56 | $100,592.20 | -13.8% | +82.8% | +1.4% | |
| Jul 17, 2024 | CADL Candel Therapeutics, Inc. | Chief Scientific Officer | Sell | 14,051 | $6.47 | $90,946.50 | -8.1% | -9.4% | +5.3% | |
| Jul 11, 2024 | CADL Candel Therapeutics, Inc. | Chief Scientific Officer | Sell | 12,645 | $5.97 | $75,533.64 | -6.8% | +1.4% | -1.7% | |
| Dec 8, 2022 | CADL Candel Therapeutics, Inc. | Chief Scientific Officer | Buy | 1,238 | $1.61 | $1,993.18 | +82.5% | +5.3% | -52.6% |